Your browser doesn't support javascript.
loading
Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin Lymphoma.
Gamboa-Cedeño, Angélica María; Díaz, Mariángeles; Cristaldo, Nancy; Otero, Victoria; Schutz, Natalia; Fantl, Dorotea; Cugliari, Silvana; Zerga, Marta; Rojas-Bilbao, Erica; Jauk, Federico; García Rivello, Hernán; Nuñez, Myriam; Ranuncolo, Stella Maris.
Afiliação
  • Gamboa-Cedeño AM; Traslational Medicine and Biomedical Engineering Institute (IMTIB), Buenos Aires, Argentina.
  • Díaz M; Research Area, Institute of Oncology "A.H. Roffo", School of Medicine (FMED), Universidad de Buenos Aires, Buenos Aires, Argentina; National Scientific and Technical Research Council (CONICET), Argentina.
  • Cristaldo N; Hematology, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina.
  • Otero V; Hematology, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina.
  • Schutz N; Hematology, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina.
  • Fantl D; Hematology, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina.
  • Cugliari S; Hematology, Institute of Oncology "A.H. Roffo", School of Medicine (FMED), Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Zerga M; Hematology, Institute of Oncology "A.H. Roffo", School of Medicine (FMED), Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Rojas-Bilbao E; Pathology, Institute of Oncology "A.H. Roffo", School of Medicine (FMED), Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Jauk F; Sequencing Laboratory, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina.
  • García Rivello H; Pathology, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina.
  • Nuñez M; School of Pharmacy and Biochemistry (FFyB), Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Ranuncolo SM; Traslational Medicine and Biomedical Engineering Institute (IMTIB), Buenos Aires, Argentina; Research Area, Institute of Oncology "A.H. Roffo", School of Medicine (FMED), Universidad de Buenos Aires, Buenos Aires, Argentina; National Scientific and Technical Research Council (CONICET), Argentina. El
Life Sci ; 268: 118979, 2021 Mar 01.
Article em En | MEDLINE | ID: mdl-33421528
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Doença de Hodgkin / Compostos Bicíclicos Heterocíclicos com Pontes / Proteínas Proto-Oncogênicas c-bcl-2 / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Life Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Argentina
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Doença de Hodgkin / Compostos Bicíclicos Heterocíclicos com Pontes / Proteínas Proto-Oncogênicas c-bcl-2 / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Life Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Argentina